Financial Snapshot

Revenue
$4.477M
TTM
Gross Margin
35.77%
TTM
Net Earnings
-$2.920K
TTM
Current Assets
$950.3K
Q2 2024
Current Liabilities
$341.2K
Q2 2024
Current Ratio
278.53%
Q2 2024
Total Assets
$2.618M
Q2 2024
Total Liabilities
$341.2K
Q2 2024
Book Value
$2.277M
Q2 2024
Cash
$555.6K
Q2 2024
P/E
-8.210K
Nov 29, 2024 EST
Free Cash Flow
$96.64K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue $3.485M $1.768M $122.8K $33.03K $33.00K $15.30K $537.7K $1.014M $150.8K $0.00 $0.00 $80.00K $310.0K $1.460M $280.0K $250.0K $260.0K $260.0K
YoY Change 97.08% 1339.92% 271.81% 0.09% 115.69% -97.15% -46.96% 572.43% -100.0% -74.19% -78.77% 421.43% 12.0% -3.85% 0.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue $3.485M $1.768M $122.8K $33.03K $33.00K $15.30K $537.7K $1.014M $150.8K $0.00 $0.00 $80.00K $310.0K $1.460M $280.0K $250.0K $260.0K $260.0K
Cost Of Revenue $2.282M $1.312M $92.29K $15.55K $18.50K $16.26K $290.9K $710.9K $64.29K $0.00 $0.00 $80.00K $260.0K $1.250M $230.0K $160.0K $170.0K $170.0K
Gross Profit $1.203M $456.8K $30.52K $17.48K $14.50K -$960.00 $246.8K $302.8K $86.46K $0.00 $0.00 $10.00K $50.00K $210.0K $60.00K $90.00K $90.00K $90.00K
Gross Profit Margin 34.53% 25.83% 24.85% 52.92% 43.94% -6.27% 45.91% 29.87% 57.35% 12.5% 16.13% 14.38% 21.43% 36.0% 34.62% 34.62%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Selling, General & Admin $1.888M $1.269M $1.751M $886.0K $1.437M $1.947M $2.016M $2.428M $1.285M $740.0K $190.0K $390.0K $1.480M $4.270M $1.310M $2.050M $640.0K $640.0K
YoY Change 48.84% -27.56% 97.67% -38.35% -26.18% -3.44% -16.94% 88.88% 73.68% 289.47% -51.28% -73.65% -65.34% 225.95% -36.1% 220.31% 0.0%
% of Gross Profit 156.91% 277.74% 5738.27% 5068.42% 9911.59% 816.83% 801.75% 1486.53% 3900.0% 2960.0% 2033.33% 2183.33% 2277.78% 711.11% 711.11%
Research & Development $242.3K $208.8K $930.00 $30.00K $30.00K
YoY Change 16.06% 22349.46% -96.9% 0.0%
% of Gross Profit 98.16% 68.95% 1.08%
Depreciation & Amortization $420.1K $630.00 $17.98K $0.00 $180.5K $535.5K $13.86K $14.67K $8.510K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $20.00K $20.00K
YoY Change 66577.78% -96.5% -100.0% -66.3% 3763.71% -5.52% 72.39% -100.0% -50.0% 0.0%
% of Gross Profit 34.91% 0.14% 58.91% 0.0% 1244.62% 5.61% 4.85% 9.84% 0.0% 0.0% 0.0% 0.0% 11.11% 22.22% 22.22%
Operating Expenses $1.897M $1.275M $1.776M $886.0K $1.618M $2.473M $2.272M $2.636M $1.286M $770.0K $200.0K $390.0K $1.490M $4.270M $1.310M $2.070M $660.0K $660.0K
YoY Change 48.79% -28.23% 100.47% -45.23% -34.59% 8.83% -13.8% 104.97% 67.04% 285.0% -48.72% -73.83% -65.11% 225.95% -36.71% 213.64% 0.0%
Operating Profit -$693.2K -$818.0K -$1.746M -$868.5K -$1.603M -$2.474M -$2.026M -$2.334M -$1.200M -$770.0K -$200.0K -$380.0K -$1.440M -$4.060M -$1.250M -$1.980M -$570.0K -$570.0K
YoY Change -15.25% -53.14% 100.99% -45.83% -35.2% 22.14% -13.2% 94.51% 55.81% 285.0% -47.37% -73.61% -64.53% 224.8% -36.87% 247.37% 0.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Interest Expense -$3.370K $8.380K -$38.01K -$159.0K -$4.730K $1.610K -$260.00 $8.480K $180.00 $0.00 $0.00 -$10.00K $0.00 $70.00K $80.00K $40.00K $0.00 $0.00
YoY Change -140.21% -122.05% -76.09% 3260.47% -393.79% -719.23% -103.07% 4611.11% -100.0% -100.0% -12.5% 100.0%
% of Operating Profit
Other Income/Expense, Net -$4.590K -$8.670K $0.00 $2.100K $440.00 $35.10K $2.950K $9.120K $0.00 $0.00 $0.00 $0.00
YoY Change -47.06% -100.0% 377.27% -98.75% 1089.83% -67.65%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Pretax Income -$701.2K -$818.2K -$1.708M -$1.174M -$1.916M -$3.458M -$2.737M -$2.614M -$1.190M -$730.0K $280.0K -$310.0K -$1.880M -$3.990M -$1.190M -$1.940M -$560.0K -$560.0K
YoY Change -14.3% -52.1% 45.5% -38.74% -44.59% 26.36% 4.7% 119.58% 63.07% -360.71% -190.32% -83.51% -52.88% 235.29% -38.66% 246.43% 0.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$701.2K -$818.2K -$1.708M -$1.174M -$2.106M -$4.137M -$2.737M -$2.614M -$1.190M -$730.0K $280.0K -$310.0K -$1.880M -$3.990M -$1.190M -$1.940M -$560.0K -$560.0K
YoY Change -14.3% -52.1% 45.5% -44.25% -49.1% 51.16% 4.7% 119.58% 63.07% -360.71% -190.32% -83.51% -52.88% 235.29% -38.66% 246.43% 0.0%
Net Earnings / Revenue -20.12% -46.27% -1390.87% -3554.25% -6380.64% -27037.91% -508.96% -257.86% -789.66% -387.5% -606.45% -273.29% -425.0% -776.0% -215.38% -215.38%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$18.44K -$19.42K -$44.52K -$122.1K -$148.8K -$175.3K -$85.27K -$111.8K $59.45K -$192.5K -$1.205M -$2.810M -$952.0K -$1.813M -$1.000M -$1.000M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Cash & Short-Term Investments $286.6K $630.5K $2.013M $302.7K $13.80K $84.44K $559.7K $427.5K $2.136M $300.0K $620.0K $0.00 $10.00K $150.0K $1.610M $2.450M $360.0K $360.0K
YoY Change -54.55% -68.68% 564.97% 2093.62% -83.66% -84.91% 30.94% -79.99% 611.97% -51.61% -100.0% -93.33% -90.68% -34.29% 580.56% 0.0%
Cash & Equivalents $276.6K $620.5K $2.013M $302.7K $13.80K $84.44K $559.7K $427.5K $2.136M $300.0K $620.0K $0.00 $10.00K $150.0K $30.00K $340.0K $360.0K $360.0K
Short-Term Investments $10.00K $10.00K $1.590M $2.110M $2.110M
Other Short-Term Assets $38.63K $30.23K $54.47K $125.4K $179.1K $286.3K $453.0K $41.14K $63.90K $0.00 $0.00 $10.00K $30.00K $210.0K $50.00K $30.00K $10.00K $10.00K
YoY Change 27.79% -44.5% -56.58% -29.97% -37.43% -36.8% 1001.0% -35.62% -100.0% -66.67% -85.71% 320.0% 66.67% 200.0% 0.0%
Inventory $20.68K $0.00 $102.5K $211.2K $1.056M $1.141M $356.3K $0.00 $90.00K $590.0K $60.00K $10.00K $20.00K $20.00K
Prepaid Expenses
Receivables $421.0K $748.1K $83.85K $11.93K $15.47K $280.3K $450.4K $719.4K $113.2K $0.00 $0.00 $10.00K $60.00K $160.0K $50.00K $40.00K $30.00K $30.00K
Other Receivables $6.690K $22.27K $7.700K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $290.0K $290.0K
Total Short-Term Assets $773.6K $1.431M $2.159M $440.1K $208.4K $753.5K $1.674M $2.244M $3.454M $310.0K $630.0K $20.00K $190.0K $1.110M $1.780M $2.530M $700.0K $700.0K
YoY Change -45.95% -33.71% 390.58% 111.18% -72.34% -55.0% -25.4% -35.02% 1014.15% -50.79% 3050.0% -89.47% -82.88% -37.64% -29.64% 261.43% 0.0%
Property, Plant & Equipment $1.718M $1.108M $90.88K $0.00 $21.01K $89.72K $31.02K $39.35K $30.00K $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $0.00 $0.00
YoY Change 55.06% 1119.18% -100.0% -76.58% 189.23% -21.17% 31.17% -100.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $240.0K $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $1.765M $1.138M $122.4K $0.00 $0.00 $446.7K $1.226M $31.02K $39.35K $510.0K $170.0K $0.00 $0.00 $240.0K $0.00 $0.00 $150.0K $150.0K
YoY Change 55.09% 829.77% -100.0% -63.56% 3851.77% -21.17% -92.28% 200.0% -100.0% -100.0% 0.0%
Total Assets $2.538M $2.569M $2.281M $440.1K $208.4K $1.200M $2.900M $2.275M $3.493M $820.0K $800.0K $20.00K $190.0K $1.350M $1.780M $2.530M $850.0K $850.0K
YoY Change
Accounts Payable $428.7K $261.5K $44.48K $152.6K $652.5K $314.2K $302.1K $357.3K $246.2K $110.0K $200.0K $330.0K $310.0K $200.0K $60.00K $60.00K $70.00K $70.00K
YoY Change 63.94% 487.88% -70.85% -76.62% 107.63% 4.02% -15.46% 45.12% 123.85% -45.0% -39.39% 6.45% 55.0% 233.33% 0.0% -14.29% 0.0%
Accrued Expenses $0.00 $10.00K $20.00K $10.00K $10.00K
YoY Change -50.0% 100.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $40.00K $40.00K $40.00K $1.002M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $40.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 0.0% 0.0% -96.01% -100.0%
Long-Term Debt Due $0.00 $21.39K $0.00 $30.00K $80.00K $990.0K $950.0K $680.0K $680.0K
YoY Change -100.0% -100.0% -62.5% -91.92% 4.21% 39.71% 0.0%
Total Short-Term Liabilities $529.2K $604.9K $84.48K $1.154M $673.9K $314.2K $402.1K $357.3K $246.2K $160.0K $330.0K $1.340M $1.260M $880.0K $60.00K $60.00K $70.00K $70.00K
YoY Change -12.51% 616.02% -92.68% 71.27% 114.44% -21.85% 12.52% 45.12% 53.89% -51.52% -75.37% 6.35% 43.18% 1366.67% 0.0% -14.29% 0.0%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $30.00K $0.00 $0.00 $240.0K $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $30.00K $0.00 $0.00 $240.0K $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Liabilities $529.2K $604.9K $84.48K $1.154M $673.9K $314.2K $402.1K $357.3K $246.2K $160.0K $360.0K $1.340M $1.260M $1.110M $60.00K $60.00K $70.00K $70.00K
YoY Change -12.51% 616.02% -92.68% 71.27% 114.44% -21.85% 12.52% 45.12% 53.89% -55.56% -73.13% 6.35% 13.51% 1750.0% 0.0% -14.29% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $23.974 Million

About Avricore Health Inc.

Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is engaged in the business of health data and point-of-care technologies (POCT). The company provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The firm's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company also provides bacterial and viral testing for Strep and COVID-19. The firm's wholly owned subsidiary is HealthTab Inc.

Industry: Pharmaceutical Preparations Peers: Kallo Inc.